Rachel Narozniak, MA
Advertisement
Articles by Rachel Narozniak, MA
Advertisement
Latest Updated Articles
COVID-19 Pandemic Accelerates RWD-Based Initiatives in OncologyPublished: June 23rd 2020 | Updated:
RET Inhibitor Enters the Therapeutic Ring in Multiple SettingsPublished: October 14th 2020 | Updated:
Companion Diagnostic, Targeted Therapy Approvals Rise in TandemPublished: August 23rd 2020 | Updated:
Beyond Cancer Type: New Pan-Tumor Targets EmergePublished: July 7th 2020 | Updated:
Tazemetostat Expands Follicular Lymphoma Tool KitPublished: August 18th 2020 | Updated:
Tucatinib Approval Adds Impact to HER2+ Breast Cancer ParadigmPublished: May 15th 2020 | Updated:
Advertisement
Advertisement
Trending on OncLive
1
Long-Term Cilta-Cel Data Show Low Rates of PFS Events in Standard-Risk R/R Myeloma
2
Nonresponse to Bridging Therapy and Peak ALC After Cilta-Cel Are Associated With Neurotoxicity, NRM in Myeloma
3
FDA Updates Axi-Cel Label to Remove Limitation of Use in R/R PCNSL
4
Real-World Data Support Clinical Benefit With Lifileucel in Previously Treated Advanced Melanoma
5